1. Munck A, Leung K 1997 Glucocorticoid receptors and mechanisms of action. In: Pasqualini, J, eds. Receptors and mechanism of action of steroid hormones. New York: Marcel Dekker; 311-329

2. Vingerhoeds AC, Thijssen JH, Schwarz F 1976 Spontaneous hypercortisolism without Cushing's syndrome. J.Clin.Endocrinol.Metab. 43:1128-1133

3. Chrousos GP, Vingerhoeds A, Brandon D, Eil C, Pugeat M, DeVroede M, Loriaux DL, Lipsett MB 1982 Primary cortisol resistance in man. A glucocorticoid receptor-mediated disease. J.Clin.Invest. 69:1261-1269

4. Malchoff CD, Javier EC, Malchoff DM, Martin T, Rogol A, Brandon D, Loriaux DL, Reardon GE 1990 Primary cortisol resistance presenting as isosexual precocity. J.Clin.Endocrinol.Metab. 70:503-507

5. Bronnegard M, Werner S, Gustafsson JA 1986 Primary cortisol resistance associated with a thermolabile glucocorticoid receptor in a patient with fatigue as the only symptom. J.Clin.Invest. 78:1270-1278

6. Corvol D, Funder J 1994 The enigma of pseudohypoaldosteronism. J.Clin.Endocrinol.Metab. 79:25-26

7. Zennaro MC 1996 Mineralocorticoid resistance. Steroids 61:189-192

8. McPhaul MJ, Marcelli M, Zoppi S, Griffin JE, Wilson JD 1993 Genetic basis of endocrine disease. 4. The spectrum of mutations in the androgen receptor gene that causes androgen resistance. J.Clin.Endocrinol.Metab. 76:17-23

9. Smith EP, Boyd J, Frank GR, Takahashi H, Cohen RM, Specker B, Williams TC, Lubahn DB, Korach KS 1994 Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N.Engl.J.Med. 331:1056-1061

10. Keller DW, Wiest WG, Askin FB, Johnson LW, Strickler RC 1979 Pseudocorpus luteum insufficiency: a local defect of progesterone action on endometrial stroma. J.Clin.Endocrinol.Metab. 48:127-132

11. Simpson HW, McArdle CS, Griffiths K, Turkes A, Beastall GH 1998 Progesterone resistance in women who have had breast cancer. Br.J.Obstet.Gynaecol. 105:345-351

12. Hughes MR, Malloy PJ, Kieback DG, Kesterson RA, Pike JW, Feldman D, O'Malley BW 1988 Point mutations in the human vitamin D receptor gene associated with hypocalcemic rickets. Science 242:1702-1705

13. Refetoff S, Weiss RE, Usala SJ 1993 The syndromes of resistance to thyroid hormone. Endocr.Rev. 14:348-399

14. Hewison M, Rut AR, Kristjansson K, Walker RE, Dillon MJ, Hughes MR, O'Riordan JL 1993 Tissue resistance to 1,25-dihydroxyvitamin D without a mutation of the vitamin D receptor gene. Clin.Endocrinol.(Oxf.) 39:663-670

15. Chrousos, G. P., Loriaux, D. L., and Lipsett, M. B. 1986 Steroid hormone resistance. New York, Plenum Press.

16. Cole TJ, Blendy JA, Monaghan AP, Krieglstein K, Schmid W, Aguzzi A, Fantuzzi G, Hummler E, Unsicker K, Schutz G 1995 Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation. Genes Dev. 9:1608-1621

17. Finotto S, Krieglstein K, Schober A, Deimling F, Lindner K, Bruhl B, Beier K, Metz J, Garcia-Arraras JE, Roig-Lopez JL, Monaghan P, Schmid W, Cole TJ, Kellendonk C, Tronche F, Schutz G, Unsicker K 1999 Analysis of mice carrying targeted mutations of the glucocorticoid receptor gene argues against an essential role of glucocorticoid signalling for generating adrenal chromaffin cells. Development 126:2935-2944

18. Chrousos GP 1995 The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N.Engl.J.Med. 332:1351-1362

19. Arai K, Chrousos GP 1995 Syndromes of glucocorticoid and mineralocorticoid resistance. Steroids 60:173-179

20. de Castro M, Chrousos GP 1997 Glucocorticoid resistance. Curr.Ther.Endocrinol.Metab. 6:188-189

21. Charmandari E, Kino T, Chrousos GP 2004 Familial/sporadic glucocorticoid resistance: clinical phenotype and molecular mechanisms. Ann.N.Y.Acad.Sci. 1024:168-181

22. Kino T, Vottero A, Charmandari E, Chrousos GP 2002 Familial/sporadic glucocorticoid resistance syndrome and hypertension. Ann.N.Y.Acad.Sci. 970:101-111

23. Norman M, Hearing SD 2002 Glucocorticoid resistance - what is known? Curr.Opin.Pharmacol. 2.(6.):723-729

24. Evans RM 1988 The steroid and thyroid hormone receptor superfamily. Science 240:889-895

25. Laudet V, Hanni C, Coll J, Catzeflis F, Stehelin D 1992 Evolution of the nuclear receptor gene superfamily. EMBO J. 11:1003-1013

26. Encio IJ, Detera-Wadleigh SD 1991 The genomic structure of the human glucocorticoid receptor. J.Biol.Chem. 266:7182-7188

27. Giguere V, Hollenberg SM, Rosenfeld MG, Evans RM 1986 Functional domains of the human glucocorticoid receptor. Cell 46:645-652

28. Freedman LP, Luisi BF, Korszun ZR, Basavappa R, Sigler PB, Yamamoto KR 1988 The function and structure of the metal coordination sites within the glucocorticoid receptor DNA binding domain. Nature 334:543-546

29. Bamberger CM, Schulte HM, Chrousos GP 1996 Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids. Endocr.Rev. 17:245-261

30. Hollenberg SM, Evans RM 1988 Multiple and cooperative trans-activation domains of the human glucocorticoid receptor. Cell 55:899-906

31. Chrousos GP 1999 A new "new" syndrome in the new world: is multiple postreceptor steroid hormone resistance due to a coregulator defect? J.Clin.Endocrinol.Metab. 84:4450-4453

32. Onate SA, Tsai SY, Tsai MJ, O'Malley BW 1995 Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270:1354-1357

33. Lundblad JR, Kwok RP, Laurance ME, Harter ML, Goodman RH 1995 Adenoviral E1A-associated protein p300 as a functional homologue of the transcriptional co-activator CBP. Nature 374:85-88

34. Chen JD, Evans RM 1995 A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377:454-457

35. Jenster G 1998 Coactivators and corepressors as mediators of nuclear receptor function: an update. Mol.Cell Endocrinol. 143:1-7

36. Hutchison KA, Scherrer LC, Czar MJ, Stancato LF, Chow YH, Jove R, Pratt WB 1993 Regulation of glucocorticoid receptor function through assembly of a receptor-heat shock protein complex. Ann.N.Y.Acad.Sci. 684:35-48.:35-48

37. Drouin J, Sun YL, Chamberland M, Gauthier Y, De Lean A, Nemer M, Schmidt TJ 1993 Novel glucocorticoid receptor complex with DNA element of the hormone-repressed POMC gene. EMBO J. 12:145-156

38. Stromstedt PE, Poellinger L, Gustafsson JA, Carlstedt-Duke J 1991 The glucocorticoid receptor binds to a sequence overlapping the TATA box of the human osteocalcin promoter: a potential mechanism for negative regulation. Mol.Cell Biol. 11:3379-3383

39. Sakai DD, Helms S, Carlstedt-Duke J, Gustafsson JA, Rottman FM, Yamamoto KR 1988 Hormone-mediated repression: a negative glucocorticoid response element from the bovine prolactin gene. Genes Dev. 2:1144-1154

40. Schule R, Rangarajan P, Kliewer S, Ransone LJ, Bolado J, Yang N, Verma IM, Evans RM 1990 Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor. Cell 62:1217-1226

41. Caldenhoven E, Liden J, Wissink S, Van de Stolpe A, Raaijmakers J, Koenderman L, Okret S, Gustafsson JA, Van der Saag PT 1995 Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids. Mol.Endocrinol. 9:401-412

42. Stocklin E, Wissler M, Gouilleux F, Groner B 1996 Functional interactions between Stat5 and the glucocorticoid receptor. Nature 383:726-728

43. Vottero A, Chrousos GP 1999 Glucocorticoid Receptor beta: View I. Trends.Endocrinol.Metab. 10:333-338

44. de Castro M, Elliot S, Kino T, Bamberger C, Karl M, Webster E, Chrousos GP 1996 The non-ligand binding beta-isoform of the human glucocorticoid receptor (hGR beta): tissue levels, mechanism of action, and potential physiologic role. Mol.Med. 2:597-607

45. Oakley RH, Sar M, Cidlowski JA 1996 The human glucocorticoid receptor beta isoform. Expression, biochemical properties, and putative function. J.Biol.Chem. 271:9550-9559

46. Kino T, Stauber RH, Resau JH, Pavlakis GN, Chrousos GP 2001 Pathologic human GR mutant has a transdominant negative effect on the wild-type GR by inhibiting its translocation into the nucleus: importance of the ligand-binding domain for intracellular GR trafficking. J.Clin.Endocrinol.Metab. 86.(11.):5600-5608

47. Lamberts SW, Poldermans D, Zweens M, de Jong FH 1986 Familial cortisol resistance: differential diagnostic and therapeutic aspects. J.Clin.Endocrinol.Metab. 63:1328-1333

48. Karl M, Lamberts SW, Koper JW, Katz DA, Huizenga NE, Kino T, Haddad BR, Hughes MR, Chrousos GP 1996 Cushing's disease preceded by generalized glucocorticoid resistance: clinical consequences of a novel, dominant-negative glucocorticoid receptor mutation. Proc.Assoc.Am.Physicians. 108:296-307

49. Vanderbilt JN, Miesfeld R, Maler BA, Yamamoto KR 1987 Intracellular receptor concentration limits glucocorticoid-dependent enhancer activity. Mol.Endocrinol. 1:68-74

50. Danielsen M, Stallcup MR 1984 Down-regulation of glucocorticoid receptors in mouse lymphoma cell variants. Mol.Cell Biol. 4:449-453

51. Gehring U, Mugele K, Ulrich J 1984 Cellular receptor levels and glucocorticoid responsiveness of lymphoma cells. Mol.Cell Endocrinol. 36:107-113

52. Kino T, De Martino MU, Charmandari E, Mirani M, Chrousos GP 2003 Tissue glucocorticoid resistance/hypersensitivity syndromes. J.Steroid Biochem.Mol.Biol. 85:457-467

53. Schaaf MJ, Cidlowski JA 2002 Molecular mechanisms of glucocorticoid action and resistance. J.Steroid Biochem.Mol.Biol. 83:37-48

54. Chrousos GP, Detera-Wadleigh SD, Karl M 1993 Syndromes of glucocorticoid resistance. Ann.Intern.Med. 119:1113-1124

55. Nawata H, Sekiya K, Higuchi K, Kato K, Ibayashi H 1987 Decreased deoxyribonucleic acid binding of glucocorticoid-receptor complex in cultured skin fibroblasts from a patient with the glucocorticoid resistance syndrome. J.Clin.Endocrinol.Metab. 65:219-226

56. Iida S, Gomi M, Moriwaki K, Itoh Y, Hirobe K, Matsuzawa Y, Katagiri S, Yonezawa T, Tarui S 1985 Primary cortisol resistance accompanied by a reduction in glucocorticoid receptors in two members of the same family. J.Clin.Endocrinol.Metab. 60:967-971

57. Vecsei P, Frank K, Haack D, Heinze V, Ho AD, Honour JW, Lewicka S, Schoosch M, Ziegler R 1989 Primary glucocorticoid receptor defect with likely familial involvement. Cancer Res. 49:2220s-2221s

58. Lamberts SW, Koper JW, Biemond P, den Holder FH, de Jong FH 1992 Cortisol receptor resistance: the variability of its clinical presentation and response to treatment. J.Clin.Endocrinol.Metab. 74:313-321

59. Hurley DM, Accili D, Stratakis CA, Karl M, Vamvakopoulos N, Rorer E, Constantine K, Taylor SI, Chrousos GP 1991 Point mutation causing a single amino acid substitution in the hormone binding domain of the glucocorticoid receptor in familial glucocorticoid resistance. J.Clin.Invest. 87:680-686

60. Karl M, Lamberts SW, Detera-Wadleigh SD, Encio IJ, Stratakis CA, Hurley DM, Accili D, Chrousos GP 1993 Familial glucocorticoid resistance caused by a splice site deletion in the human glucocorticoid receptor gene. J.Clin.Endocrinol.Metab. 76:683-689

61. Malchoff DM, Brufsky A, Reardon G, McDermott P, Javier EC, Bergh CH, Rowe D, Malchoff CD 1993 A mutation of the glucocorticoid receptor in primary cortisol resistance. J.Clin.Invest. 91:1918-1925

62. Vottero A, Kino T, Combe H, Lecomte P, Chrousos GP 2002 A novel, C-terminal dominant negative mutation of the GR causes familial glucocorticoid resistance through abnormal interactions with p160 steroid receptor coactivators. J.Clin.Endocrinol.Metab. 87:2658-2667

63. Mendonca BB, Leite MV, de Castro M, Kino T, Elias LL, Bachega TA, Arnhold IJ, Chrousos GP, Latronico AC 2002 Female pseudohermaphroditism caused by a novel homozygous missense mutation of the GR gene. J.Clin.Endocrinol.Metab. 87:1805-1809

64. Ruiz M, Lind U, Gafvels M, Eggertsen G, Carlstedt-Duke J, Nilsson L, Holtmann M, Stierna P, Wikstrom AC, Werner S 2001 Characterization of two novel mutations in the glucocorticoid receptor gene in patients with primary cortisol resistance. Clin.Endocrinol.(Oxf.) 55:363-371

65. Charmandari E, Kino T, Souvatzoglou E, Vottero A, Bhattacharyya N, Chrousos GP 2004 Natural glucocorticoid receptor mutants causing generalized glucocorticoid resistance: molecular genotype, genetic transmission, and clinical phenotype. J.Clin.Endocrinol.Metab. 89:1939-1949

66. Roux S, Terouanne B, Couette B, Rafestin-Oblin ME, Nicolas JC 1999 Conformational change in the human glucocorticoid receptor induced by ligand binding is altered by mutation of isoleucine 747 by a threonine. J.Biol.Chem. 274:10059-10065

67. Shahidi H, Vottero A, Stratakis CA, Taymans SE, Karl M, Longui CA, Chrousos GP, Daughaday WH, Gregory SA, Plate JM 1999 Imbalanced expression of the glucocorticoid receptor isoforms in cultured lymphocytes from a patient with systemic glucocorticoid resistance and chronic lymphocytic leukemia. Biochem.Biophys.Res.Commun. 254:559-565

68. Huizenga NA, de Lange P, Koper JW, de Herder WW, Abs R, Kasteren JH, de Jong FH, Lamberts SW 2000 Five patients with biochemical and/or clinical generalized glucocorticoid resistance without alterations in the glucocorticoid receptor gene. J.Clin.Endocrinol.Metab. 85:2076-2081

69. Pavlakis GN 1996 The molecular biology of HIV-1. In: DeVita, V. T., Hellman, S., and Rosenberg, S. A, eds. AIDS: diagnosis, treatment and prevention. Philadelphia: Raven; 45-74

70. Emerman M 1996 HIV-1, Vpr and the cell cycle. Curr.Biol. 6:1096-1103

71. Kino T, Gragerov A, Kopp JB, Stauber RH, Pavlakis GN, Chrousos GP 1999 The HIV-1 virion-associated protein vpr is a coactivator of the human glucocorticoid receptor. J.Exp.Med. 189:51-62

72. Leo C, Chen JD 2000 The SRC family of nuclear receptor coactivators. Gene 245:1-11

73. Jeang KT, Xiao H, Rich EA 1999 Multifaceted activities of the HIV-1 transactivator of transcription, Tat. J.Biol.Chem. 274:28837-28840

74. Kino T, Chrousos GP 2001 Glucocorticoid and mineralocorticoid resistance/hypersensitivity syndromes. J.Endocrinol.169.(3.):437-445

75. Kino T, Chrousos GP 2001 Acquired immunodeficiency syndrome-related insulin resistance and lipodystrophy: a multifactorial viral and iatrogenic condition. Endocr.Pract. 7:480-484

76. Kino T, Mirani M, Alesci S, Chrousos GP 2003 AIDS-related lipodystrophy/insulin resistance syndrome. Horm.Metab.Res. 35:129-136

77. Kino T, Slobodskaya O, Pavlakis GN, Chrousos GP 2002 Nuclear receptor coactivator p160 proteins enhance the HIV-1 long terminal repeat promoter by bridging promoter-bound factors and the Tat-P-TEFb complex. J.Biol.Chem. 277:2396-2405

78. Price DH 2000 P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II. Mol.Cell Biol. 20:2629-2634

79. Kino T, Kopp JB, Chrousos GP 2000 Glucocorticoids suppress human immunodeficiency virus type-1 long terminal repeat activity in a cell type-specific, glucocorticoid receptor-mediated fashion: direct protective effects at variance with clinical phenomenology. J.Steroid Biochem.Mol.Biol. 75:283-290

80. Imai Y, Kimura T, Murakami A, Yajima N, Sakamaki K, Yonehara S 1999 The CED-4-homologous protein FLASH is involved in Fas-mediated activation of caspase-8 during apoptosis. Nature 398:777-785

81. Kino T, Chrousos GP 2003 Tumor necrosis factor alpha receptor- and Fas-associated FLASH inhibit transcriptional activity of the glucocorticoid receptor by binding to and interfering with its interaction with p160 type nuclear receptor coactivators. J.Biol.Chem. 278:3023-3029

82. De Martino MU, Alesci S, Chrousos GP, Kino T 2004 Interaction of the glucocorticoid receptor and the chicken ovalbumin upstream promoter-transcription factor II (COUP-TFII): implications for the actions of glucocorticoids on glucose, lipoprotein, and xenobiotic metabolism. Ann.N.Y.Acad.Sci. 1024:72-85.:72-85

83. De Martino MU, Bhattachryya N, Alesci S, Ichijo T, Chrousos GP, Kino T 2004 The glucocorticoid receptor and the orphan nuclear receptor chicken ovalbumin upstream promoter-transcription factor II interact with and mutually affect each other's transcriptional activities: implications for intermediary metabolism. Mol.Endocrinol. 18:820-833

84. Bamberger CM, Bamberger AM, de Castro M, Chrousos GP 1995 Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans. J.Clin.Invest. 95:2435-2441

85. Leung DY, Hamid Q, Vottero A, Szefler SJ, Surs W, Minshall E, Chrousos GP, Klemm DJ 1997 Association of glucocorticoid insensitivity with increased expression of glucocorticoid receptor beta. J.Exp.Med. 186:1567-1574

86. Bray PJ, Cotton RG 2003 Variations of the human glucocorticoid receptor gene (NR3C1): pathological and in vitro mutations and polymorphisms. Hum.Mutat. 21:557-568

87. Ikeda Y, Suehiro T, Tsuzura S, Shiinoki T, Kaneda T, Kumon Y, Hashimoto K 2001 A polymorphism in the promoter region of the glucocorticoid receptor gene is associated with its transcriptional activity. Endocr.J. 48:723-726

88. Chrousos GP, Renquist D, Brandon D, Eil C, Pugeat M, Vigersky R, Cutler GBJ, Loriaux DL, Lipsett MB 1982 Glucocorticoid hormone resistance during primate evolution: receptor-mediated mechanisms. Proc.Natl.Acad.Sci.U.S A. 79:2036-2040

89. Brandon DD, Markwick AJ, Flores M, Dixon K, Albertson BD, Loriaux DL 1991 Genetic variation of the glucocorticoid receptor from a steroid-resistant primate. J.Mol.Endocrinol. 7:89-96

90. Chrousos GP, Brandon D, Renquist DM, Tomita M, Johnson E, Loriaux DL, Lipsett MB 1984 Uterine estrogen and progesterone receptors in an estrogen- and progesterone- "resistant" primate. J.Clin.Endocrinol.Metab. 58:516-520

91. Gacad MA, Adams JS 1991 Endogenous blockade of 1,25-dihydroxyvitamin D-receptor binding in New World primate cells. J.Clin.Invest. 87:996-1001

92. Keightley MC, Fuller PJ 1994 Unique sequences in the guinea pig glucocorticoid receptor induce constitutive transactivation and decrease steroid sensitivity. Mol.Endocrinol. 8:431-439

93. Keightley MC, Curtis AJ, Chu S, Fuller PJ 1998 Structural determinants of cortisol resistance in the guinea pig glucocorticoid receptor. Endocrinology 139:2479-2485

94. Taymans SE, DeVries AC, DeVries MB, Nelson RJ, Friedman TC, Castro M, Detera-Wadleigh S, Carter CS, Chrousos GP 1997 The hypothalamic-pituitary-adrenal axis of prairie voles (Microtus ochrogaster): evidence for target tissue glucocorticoid resistance. Gen.Comp.Endocrinol. 106:48-61

95. New MI, Nimkarn S, Brandon DD, Cunningham-Rundles S, Wilson RC, Newfield RS, Vandermeulen J, Barron N, Russo C, Loriaux DL, O'Malley B 1999 Resistance to several steroids in two sisters. J.Clin.Endocrinol.Metab. 84:4454-4464